All together our findings indicate that PTOV1 confers prostate cancer cells the advantages to survive docetaxel toxicity, through upregulation of ABCB1 and genes associated to docetaxel resistance and pluripotency factors. The gene discussed is ABCB1; the disease is Familial prostate cancer.